These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 32535296
1. Time to sputum culture conversion and its associated factors among multidrug-resistant tuberculosis patients in Eastern Africa: A systematic review and meta-analysis. Assemie MA, Alene M, Petrucka P, Leshargie CT, Ketema DB. Int J Infect Dis; 2020 Sep; 98():230-236. PubMed ID: 32535296 [Abstract] [Full Text] [Related]
2. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome. Holtz TH, Sternberg M, Kammerer S, Laserson KF, Riekstina V, Zarovska E, Skripconoka V, Wells CD, Leimane V. Ann Intern Med; 2006 May 02; 144(9):650-9. PubMed ID: 16670134 [Abstract] [Full Text] [Related]
3. Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia. Shibabaw A, Gelaw B, Wang SH, Tessema B. PLoS One; 2018 May 02; 13(6):e0198080. PubMed ID: 29944658 [Abstract] [Full Text] [Related]
4. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia. Putri FA, Burhan E, Nawas A, Soepandi PZ, Sutoyo DK, Agustin H, Isbaniah F, Dowdy DW. Int J Tuberc Lung Dis; 2014 May 02; 18(5):564-70. PubMed ID: 24903794 [Abstract] [Full Text] [Related]
5. Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis. Kurbatova EV, Gammino VM, Bayona J, Becerra MC, Danilovitz M, Falzon D, Gelmanova I, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riekstina V, Taylor A, Viiklepp P, Zignol M, Cegielski JP. Int J Tuberc Lung Dis; 2012 Oct 02; 16(10):1335-43. PubMed ID: 23107633 [Abstract] [Full Text] [Related]
6. Determinants of sputum culture conversion time in multidrug-resistant tuberculosis patients in ALERT comprehensive specialized hospital, Addis Ababa, Ethiopia: A retrospective cohort study. Abebe M, Atnafu A, Tilahun M, Sero N, Neway S, Alemu M, Tesfaye G, Mihret A, Bobosha K, Wan C. PLoS One; 2024 Oct 02; 19(5):e0304507. PubMed ID: 38820260 [Abstract] [Full Text] [Related]
7. Time to sputum culture conversion and its associated factors among drug-resistant tuberculosis patients: a systematic review and meta-analysis. Wenlu Y, Xia Z, Chuntao W, Qiaolin Y, Xujue X, Rong Y, Dan S, Xi Y, Bin W. BMC Infect Dis; 2024 Feb 07; 24(1):169. PubMed ID: 38326758 [Abstract] [Full Text] [Related]
8. Cigarette smoking and culture conversion in patients with susceptible and M/XDR-TB. Reimann M, Schaub D, Kalsdorf B, Runge C, Carballo PS, Terhalle E, Salzer HJF, Lange C, Heyckendorf J. Int J Tuberc Lung Dis; 2019 Jan 01; 23(1):93-98. PubMed ID: 30674380 [Abstract] [Full Text] [Related]
9. Factors affecting time to sputum culture conversion and treatment outcome of patients with multidrug-resistant tuberculosis in China. Liu Q, Lu P, Martinez L, Yang H, Lu W, Ding X, Zhu L. BMC Infect Dis; 2018 Mar 06; 18(1):114. PubMed ID: 29510666 [Abstract] [Full Text] [Related]
13. Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies. Kurbatova EV, Cegielski JP, Lienhardt C, Akksilp R, Bayona J, Becerra MC, Caoili J, Contreras C, Dalton T, Danilovits M, Demikhova OV, Ershova J, Gammino VM, Gelmanova I, Heilig CM, Jou R, Kazennyy B, Keshavjee S, Kim HJ, Kliiman K, Kvasnovsky C, Leimane V, Mitnick CD, Quelapio I, Riekstina V, Smith SE, Tupasi T, van der Walt M, Vasilyeva IA, Via LE, Viiklepp P, Volchenkov G, Walker AT, Wolfgang M, Yagui M, Zignol M. Lancet Respir Med; 2015 Mar 06; 3(3):201-9. PubMed ID: 25726085 [Abstract] [Full Text] [Related]
15. Time to sputum culture conversion and treatment outcome among the first cohort of multidrug resistant tuberculosis patients in a high burden country. Ige OM, Oladokun RE. Indian J Tuberc; 2018 Oct 06; 65(4):322-328. PubMed ID: 30522620 [Abstract] [Full Text] [Related]
16. Evaluation of six months sputum culture conversion as a surrogate endpoint in a multidrug resistant-tuberculosis trial. Meyvisch P, Kambili C, Andries K, Lounis N, Theeuwes M, Dannemann B, Vandebosch A, Van der Elst W, Molenberghs G, Alonso A. PLoS One; 2018 Oct 06; 13(7):e0200539. PubMed ID: 30024924 [Abstract] [Full Text] [Related]
17. Chest radiograph findings and time to culture conversion in patients with multidrug-resistant tuberculosis and HIV in Tugela Ferry, South Africa. Brust JC, Berman AR, Zalta B, Haramati LB, Ning Y, Heo M, van der Merwe TL, Bamber S, Moll AP, Friedland GH, Shah NS, Gandhi NR. PLoS One; 2013 Oct 06; 8(9):e73975. PubMed ID: 24040132 [Abstract] [Full Text] [Related]
19. Improved treatment outcome of multidrug-resistant tuberculosis with the use of a rapid molecular test to detect drug resistance in China. Shi W, Davies Forsman L, Hu Y, Zheng X, Gao Y, Li X, Jiang W, Bruchfeld J, Diwan VK, Hoffner S, Xu B. Int J Infect Dis; 2020 Jul 06; 96():390-397. PubMed ID: 32353546 [Abstract] [Full Text] [Related]
20. How many sputum culture results do we need to monitor multidrug-resistant-tuberculosis (MDR-TB) patients during treatment? Janssen S, Padanilam X, Louw R, Mahanyele R, Coetzee G, Hänscheid T, Leenstra T, Grobusch MP. J Clin Microbiol; 2013 Feb 06; 51(2):644-6. PubMed ID: 23224098 [Abstract] [Full Text] [Related] Page: [Next] [New Search]